Operating
Change in AR
Gilead Sciences Change in AR increased by 14.0% to $333.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 305.6%, from -$162.00M to $333.00M. Over 3 years (FY 2021 to FY 2024), Change in AR shows an upward trend with a -23.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
A large increase relative to sales growth may signal issues with collections or aggressive credit terms offered to customers.
Detailed definition
This represents the net change in the amount of money owed to the company by customers for goods or services delivered o...
Peer comparison
Companies with strong market power or direct-to-consumer models typically maintain lower accounts receivable relative to total sales.
Metric ID:
cf_change_in_accounts_receivableHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $281.00M | $422.00M | -$41.00M | -$699.00M | $452.00M | $372.00M | $281.00M | -$635.00M | $86.00M | $612.00M | -$220.00M | $66.00M | $29.00M | -$162.00M | -$72.00M | -$79.00M | $292.00M | $333.00M |
| QoQ Change | — | +50.2% | -109.7% | <-999% | +164.7% | -17.7% | -24.5% | -326.0% | +113.5% | +611.6% | -135.9% | +130.0% | -56.1% | -658.6% | +55.6% | -9.7% | +469.6% | +14.0% |
| YoY Change | — | — | — | — | +60.9% | -11.8% | +785.4% | +9.2% | -81.0% | +64.5% | -178.3% | +110.4% | -66.3% | -126.5% | +67.3% | -219.7% | +906.9% | +305.6% |
Range-$699.00M – $612.00M
CAGR+4.1%
Avg YoY Growth+116.2%
Median YoY Growth+35.0%
Current Streak2 quarters growth
Change in AR at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's change in ar?
- Gilead Sciences (GILD) reported change in ar of $333.00M in Q3 2025.
- How has Gilead Sciences's change in ar changed year-over-year?
- Gilead Sciences's change in ar increased by 305.6% year-over-year, from -$162.00M to $333.00M.
- What is the long-term trend for Gilead Sciences's change in ar?
- Over 3 years (2021 to 2024), Gilead Sciences's change in ar has grown at a -23.7% compound annual growth rate (CAGR), from -$313.00M to -$139.00M.
- What does change in ar mean?
- The change in the amount of money customers owe the company for recent purchases.